Advertisement

Journal of Immigrant and Minority Health

, Volume 16, Issue 4, pp 751–755 | Cite as

Late Presentation and Loss to Follow-Up of Immigrants Newly Diagnosed with HIV in the HAART Era

  • A. Saracino
  • A. Tartaglia
  • G. Trillo
  • C. Muschitiello
  • C. Bellacosa
  • G. Brindicci
  • L. Monno
  • G. Angarano
Brief Communication

Abstract

To compare clinical characteristics and therapeutic management of newly HIV-diagnosed immigrants to natives. Patients with a first HIV diagnosis from 1996 to 2010 were included. Of 716 new diagnoses, 85 (12 %) were immigrants. Migrants were younger, more frequently females and sexually infected, less likely to voluntarily request testing, and less HCV-coinfected. Late presenters (CD4 <350 or AIDS) were 76 % among migrants versus 56 % in natives (p = 0.006) with an increasing trend over time. HAART was initiated in 76.5 % of natives and 72.4 % of immigrants; the number/type of adverse events and treatment discontinuation were similar. Immigrants received more NNRTIs-based regimens. A similar proportion of patients reached virological suppression at month 1–3–6 after HAART initiation, but 43 % of immigrants versus 27 % of natives resulted lost to follow-up (p < 0.001). Diagnosis of HIV was often delayed among migrants, who also presented a higher rate of lost to follow-up.

Keywords

HIV/AIDS Immigrants Late presenters HAART 

Notes

Acknowledgments

We gratefully acknowledge Mrs. Paulene Butts for the helpful review of the manuscript.

References

  1. 1.
    Istituto Superiore Di Sanità (ISS)-Centro Operativo AIDS (CoA). Aggiornamento delle nuove diagnosi di infezione da HIV e dei casi di AIDS in Italia al 31 Dicembre 2011. Not Ist Super Sanità. 2012;25(10 Suppl 1):3–46.Google Scholar
  2. 2.
    Saracino A, El-Hamad I, Prato R, Cibelli DC, Tartaglia A, Palumbo E, Pezzoli MC, Angarano G, Scotto G, The SIMIT Study Group. Access to HAART in HIV-infected immigrants: a retrospective multicenter Italian study. AIDS Patient Care STDS. 2005;19:599–606.PubMedCrossRefGoogle Scholar
  3. 3.
    Pérez Molina JA, Rillo MM, Suárez-Lozano I, Casado Osorio JL, Cobo RT, González PR, Clotet EP, Jerez AH, Pedrol PD, Royuela A, Díaz EB, Esteban H, González-García J. Do HIV-infected immigrants initiating HAART have poorer treatment-related outcomes than autochthonous patients in Spain? Results of the GESIDA 5808 Study. Curr HIV Res. 2010;8(7):521–30.PubMedCrossRefGoogle Scholar
  4. 4.
    Fakoya I, Reynolds R, Caswell G, Shiripinda I. Barriers to HIV testing for migrant black Africans in Western Europe. HIV Med. 2008;9(Suppl 2):23–5. (review).PubMedCrossRefGoogle Scholar
  5. 5.
    Egger M, May M, Chêne G, Phillips AN, Ledergerber B, Dabis F, Costagliola D, D’Arminio Monforte A, de Wolf F, Reiss P, Lundgren JD, Justice AC, Staszewski S, Leport C, Hogg RS, Sabin CA, Gill MJ, Salzberger B, Sterne JA, ART Cohort Collaboration. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360(9327):119–29.PubMedCrossRefGoogle Scholar
  6. 6.
    Montaner JS, Lima VD, Barrios R, Yip B, Wood E, Kerr T, Shannon K, Harrigan PR, Hogg RS, Daly P, Kendall P. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010;376(9740):532–9.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Fleishman JA, Yehia BR, Moore RD, Gebo KA, HIV Research Network. The economic burden of late entry into medical care for patients with HIV infection. Med Care. 2010;48(12):1071–9.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Staehelin C, Keiser O, Calmy A, Weber R, Elzi L, Cavassini M, Schmid P, Bernasconi E, Furrer H, Swiss HIV Cohort Study. Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2012;59(1):79–85.PubMedCrossRefGoogle Scholar
  9. 9.
    Yebra G, de Mulder M, Pérez-Elías MJ, Pérez-Molina JA, Galán JC, Llenas-García J, Moreno S, Holguín A. Increase of transmitted drug resistance among HIV-infected Sub-Saharan Africans residing in Spain in contrast to the native population. PLoS One. 2011;6(10):e26757.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Thierfelder C, Weber R, Elzi L, Furrer H, Cavassini M, Calmy A, Bernasconi E, Gutmann C, Ledergerber B, Swiss HIV Cohort Study Group. Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. HIV Med. 2012;13(2):118–26.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • A. Saracino
    • 1
    • 2
  • A. Tartaglia
    • 3
  • G. Trillo
    • 2
  • C. Muschitiello
    • 4
  • C. Bellacosa
    • 3
  • G. Brindicci
    • 2
  • L. Monno
    • 2
  • G. Angarano
    • 2
    • 3
  1. 1.Clinic of Infectious DiseasesUniversity of FoggiaFoggiaItaly
  2. 2.Clinic of Infectious DiseasesUniversity of BariBariItaly
  3. 3.Institute of Health, Migration and Poverty (INMP)RomeItaly
  4. 4.Carlo Cecchi Department of StatisticsUniversity of BariBariItaly

Personalised recommendations